Accretion Nutraveda
ANLBSE

Accretion Nutraveda

₹296.008.00 (2.78%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
296.00
Today’s high
296.00
52 week low
150.10
52 week high
313.00
Open price
296.00
Previous close
288.00
Live volume
63,000
Lower circuit
236.80
Upper circuit
355.20

Fundamentals

Market Cap
₹209Cr
ROE
14.29%
P/E Ratio(TTM)
0.00
EPS(TTM)
0.00
P/B Ratio
5.88
Dividend Yield
0.00%
Industry P/E
50.28
Book Value
49.00
Debt to Equity
0.12
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
2026
₹33.72Cr
+110.62%
₹5.07Cr
+102.66%
010203040
2023
2024
2025
2026
Revenue growthValue
3Y CAGR+122%
Profit growthValue
3Y CAGR+162%

About

Accretion Nutraveda functions as a CDMO (Contract Development and Manufacturing Organisation). It combines traditional Ayurvedic principles with modern nutraceutical science to serve both domestic and international markets.;
CEO/MD
Mayur Popatlal Sojitra
Founded in
2021
BSE symbol
544694

Shareholding pattern

Sep '25
Jan '26
Feb '26
Mar '26
Jun '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,596.60
+13.60 (0.53%)
L
    H
    19,728.4629.15.85
    PfizerPFIZER
    ₹4,014.80
    +0.40 (0.01%)
    L
      H
      18,372.5224.994.37
      ₹6,669.00
      -34.00 (0.51%)
      L
        H
        16,686.3898.3719.12
        ₹1,012.10
        +9.60 (0.96%)
        L
          H
          16,121.9645.882.27
          2026
          8
          May
          Annual Result
          Release date
          Events calendar
          View upcoming events in other stocks